HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Angel Chao Selected Research
Angel Chao Research Topics
Disease
43
Neoplasms (Cancer)
02/2022 - 08/2002
22
Endometrial Neoplasms (Endometrial Cancer)
02/2022 - 01/2006
14
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2018 - 04/2004
10
Carcinoma (Carcinomatosis)
11/2021 - 07/2004
10
Ovarian Neoplasms (Ovarian Cancer)
07/2021 - 09/2010
7
Endometriosis
11/2021 - 11/2008
7
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 05/2009
5
Neoplasm Metastasis (Metastasis)
11/2021 - 09/2007
4
Uterine Cervical Dysplasia
07/2012 - 04/2004
3
Carcinogenesis
01/2021 - 02/2013
3
Cicatrix (Scar)
01/2018 - 07/2005
3
Infections
01/2012 - 07/2009
3
Fever (Fevers)
10/2009 - 08/2002
2
Lymphatic Metastasis
11/2021 - 11/2010
2
Disease Progression
07/2021 - 12/2014
2
Myoma
07/2020 - 01/2018
2
Adenomyosis
04/2018 - 01/2018
2
Uterine Hemorrhage (Uterine Bleeding)
02/2011 - 07/2005
2
Choriocarcinoma
05/2010 - 08/2002
2
Abscess
07/2009 - 08/2002
1
Hyperplasia
02/2022
1
Endometrial Hyperplasia
02/2022
1
Leiomyoma (Uterine Fibroids)
01/2022
1
Carcinosarcoma
11/2021
1
Neoplasm Micrometastasis
10/2021
1
Papillomavirus Infections
01/2021
Drug/Important Bio-Agent (IBA)
11
Proteins (Proteins, Gene)
FDA Link
09/2021 - 07/2009
10
Phosphoproteins
IBA
03/2021 - 09/2010
9
DNA (Deoxyribonucleic Acid)
IBA
01/2015 - 04/2004
6
Biomarkers (Surrogate Marker)
IBA
02/2022 - 09/2010
5
RNA (Ribonucleic Acid)
IBA
11/2021 - 07/2006
5
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2018 - 10/2004
4
Estrogens (Estrogen)
FDA Link
09/2016 - 01/2012
3
MicroRNAs (MicroRNA)
IBA
02/2022 - 05/2010
3
Antigens
IBA
11/2021 - 06/2013
3
Nucleophosmin
IBA
01/2021 - 02/2013
3
Estrogen Receptors
IBA
07/2019 - 01/2013
3
Formaldehyde (Formol)
FDA Link
12/2016 - 05/2010
3
Paraffin
IBA
12/2016 - 05/2010
3
Phosphotransferases (Kinase)
IBA
09/2014 - 08/2012
3
Tumor Biomarkers (Tumor Markers)
IBA
06/2013 - 10/2004
3
squamous cell carcinoma-related antigen
IBA
11/2010 - 07/2004
3
Anti-Bacterial Agents (Antibiotics)
IBA
10/2009 - 08/2002
2
palbociclib
IBA
11/2021 - 07/2019
2
Lysine (L-Lysine)
FDA Link
03/2021 - 09/2017
2
Antibodies
IBA
03/2021 - 01/2013
2
Luciferases
IBA
03/2021 - 04/2018
2
Peptides (Polypeptides)
IBA
03/2021 - 08/2016
2
Biological Products
IBA
01/2021 - 07/2009
2
Vaccines
IBA
01/2021 - 02/2011
2
Pharmaceutical Preparations
IBA
01/2020 - 02/2016
2
Tyrosine Kinase Inhibitors
IBA
01/2020 - 09/2014
2
Acetates (Acetic Acid Esters)
FDA Link
07/2019 - 09/2016
2
Platinum
IBA
01/2018 - 02/2016
2
Cisplatin (Platino)
FDA Link
Generic
06/2017 - 02/2016
2
Lipids
IBA
01/2017 - 07/2009
2
Hormones (Hormone)
IBA
09/2016 - 02/2013
2
Heat-Shock Proteins (Heat-Shock Protein)
IBA
08/2016 - 08/2012
2
activin receptor type II-A (activin A receptor, type II)
IBA
01/2013 - 08/2012
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
02/2022
1
lenvatinib
IBA
11/2021
1
Interferons
IBA
11/2021
1
Glucose (Dextrose)
FDA Link
Generic
11/2021
1
Therapeutic Uses
IBA
11/2021
1
Protein Isoforms (Isoforms)
IBA
11/2021
1
alpha 1-Antitrypsin (alpha 1 Antitrypsin)
IBA
11/2021
1
Inhibitor of Apoptosis Proteins
IBA
10/2021
1
LCL161
IBA
10/2021
1
Topotecan (Hycamtin)
FDA Link
Generic
10/2021
1
Choline (Choline Chloride)
IBA
10/2021
1
Keratins (Keratin)
IBA
10/2021
1
Hematoxylin (Haematoxylon)
IBA
10/2021
1
Eosine Yellowish-(YS) (Eosin)
IBA
10/2021
1
Combined Antibody Therapeutics
IBA
10/2021
1
Bevacizumab (Avastin)
FDA Link
07/2021
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
04/2021
1
Janus Kinase 2
IBA
03/2021
1
Caspases
IBA
03/2021
1
HEPES
IBA
03/2021
1
Transcription Factors (Transcription Factor)
IBA
01/2021
1
Glycogen Synthase (Synthase I)
IBA
01/2021
Therapy/Procedure
12
Therapeutics
11/2021 - 09/2007
9
Drug Therapy (Chemotherapy)
11/2021 - 08/2002
6
Hysterectomy
08/2018 - 08/2002
5
Salvage Therapy
06/2014 - 07/2004
4
Adjuvant Chemotherapy
11/2021 - 10/2016
4
Aftercare (After-Treatment)
04/2020 - 02/2007
4
Chemoradiotherapy
01/2018 - 09/2016
3
Uterine Myomectomy
01/2022 - 01/2018
3
Radiotherapy
03/2014 - 11/2010
2
Cytoreduction Surgical Procedures
07/2021 - 01/2018
2
Neoadjuvant Therapy
07/2021 - 06/2017
2
Laparotomy
04/2021 - 11/2008
2
Length of Stay
01/2018 - 10/2009
2
Cesarean Section (Caesarean Section)
03/2013 - 02/2011
2
Conservative Treatment
03/2011 - 10/2010
2
Cystectomy
10/2010 - 11/2008
1
Uterine Artery Embolization
01/2022
1
Lymph Node Excision (Lymph Node Dissection)
03/2021
1
Immunotherapy
01/2021